Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
25.63Enterprise Value over EBITDA
VS
Market
Sector
Industry
History
$ 0.71Close
$ 0.35 - $ 0.8 52-Week Range
Ticker Information
Ticker
XTNTCompany Name
XTANT MEDICAL HOLDINGS INCSector
HealthcareIndustry
Medical DevicesExchange
NYSEMKTXTANT MEDICAL HOLDINGS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
XTNT - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ 4.58M | $ 117.35M | 25.63 |
| 3/31/2025 | $ -3.23M | $ 101.31M | 0 |
| 12/31/2024 | $ -7.88M | $ 95.95M | 0 |
| 9/30/2024 | $ -8.91M | $ 103.93M | 0 |
| 6/30/2024 | $ 2.36M | $ 114.47M | 48.59 |
| 3/31/2024 | $ 3.6M | $ 127.14M | 35.29 |
| 12/31/2023 | $ 5.08M | $ 151.76M | 29.9 |
| 9/30/2023 | $ 5.59M | $ 163.91M | 29.3 |
| 6/30/2023 | $ -4.51M | $ 154.45M | 0 |
| 3/31/2023 | $ -4.9M | $ 85.87M | 0 |
Key Performance Insights, Last 5 Years
- XTANT MEDICAL HOLDINGS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 151.61.
- Over the past 5 years, XTANT MEDICAL HOLDINGS INC's average EV/EBITDA has been 61.42.
- The median EV/EBITDA for XTANT MEDICAL HOLDINGS INC during this period was 48.59
- XTANT MEDICAL HOLDINGS INC reached its highest EV/EBITDA over the past 5 years at 151.61.
- The lowest EV/EBITDA recorded by XTANT MEDICAL HOLDINGS INC in the same timeframe 25.63
XTANT MEDICAL HOLDINGS INC's EV/EBITDA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBITDA Benchmarks
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for XTANT MEDICAL HOLDINGS INC is calculated as follows: EV [ $ 176.78M ] / EBITDA [ $ 1.17M ]
(=) EV/EBITDA [ 151.61 ] XTNT - Enterprise Value over EBITDA, Last 5 years
25.63
Minimum
Jun 30, 2025
151.61
Maximum
Sep 30, 2020
61.42
Average
48.59
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.48 |
| median | 11.75 |
| std | 7.65 |